NFKBIB
NFKBIB (NFKB inhibitor beta, also known as IKBB and TRIP9) is an ankyrin repeat protein of the NF-kappa-B inhibitor family. It restrains NF-kappa-B by complexing with it and trapping it in the cytoplasm. Browse Assay Genie's current range of NFKBIB research reagents below, or read on for the biology behind the target.
NFKBIB, the NF-kappa-B inhibitor beta, inhibits NF-kappa-B by complexing with it and trapping it in the cytoplasm. Phosphorylation of serine residues on inhibitors of this family by kinases marks them for destruction via the ubiquitination pathway, which allows NF-kappa-B to translocate to the nucleus and act as a transcription factor.
NFKBIB has a notable second behaviour. The unphosphorylated form that is resynthesised after cell stimulation can bind NF-kappa-B and allow its transport to the nucleus, protecting it from further NFKBIA-dependent inactivation. Association with the inhibitor kappa B-interacting proteins NKIRAS1 and NKIRAS2 prevents NFKBIB phosphorylation, making it more resistant to degradation and explaining its slower degradation. The protein is annotated in both the cytoplasm and the nucleus.
The NFKBIB gene belongs to the HGNC groups for ankyrin repeat domain containing proteins and the NFKB inhibitor family. Alternatively spliced transcript variants have been reported. The HGNC previous name is nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta, and the gene has orthologues named Nfkbib in mouse and rat. Researchers studying the NFKBIB protein often do so alongside NFKBIA, as the two inhibitors differ in their kinetics and in how they handle NF-kappa-B.
NFKBIB is a cytoplasmic inhibitor that holds NF-kappa-B in check until phosphorylation and ubiquitin-dependent destruction release it.
Phosphorylation of serine residues marks NF-kappa-B inhibitors for ubiquitination, and NKIRAS1 and NKIRAS2 slow NFKBIB degradation.
Unphosphorylated NFKBIB resynthesised after stimulation can bind NF-kappa-B and carry it to the nucleus, protecting it from NFKBIA-dependent inactivation.
By controlling when NF-kappa-B translocates to the nucleus, NFKBIB influences the activity of this transcription factor.
NFKBIB inhibits NF-kappa-B by complexing with it and trapping it in the cytoplasm. After stimulation, the unphosphorylated, newly synthesised form can instead bind NF-kappa-B, allow its transport to the nucleus and protect it from NFKBIA-dependent inactivation.
NFKBIB is also called IKBB and TRIP9, and the UniProt name is NF-kappa-B inhibitor beta. The HGNC previous name is nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta. Alternatively spliced transcript variants have been described for the gene.
Yes. Orthologues named Nfkbib are annotated in both mouse and rat. The protein belongs to the NF-kappa-B inhibitor family, which acts in the same way across the family by trapping NF-kappa-B in the cytoplasm. Check the datasheet of any product for its validated reactivity.
Other NF-κB inhibitors, NF-κB subunits and pathway regulators with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q15653; product specifications from Assay Genie datasheets.